MedTrace Logo

Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

NCT03579121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2022-06-15

No results posted yet for this study

Summary

The researchers are conducting this study to see if pharmacogenomic testing before surgery helps the doctor to choose which medications will work best for the patient.

Conditions

  • Perioperative/Postoperative Complications

Interventions

OTHER

Pharmacogenomic (PGx)

Administer a pharmacogenomics test (buccal swab) during the pre-operative setting

OTHER

Review results

Pharmacogenomic (PGx) results reviewed by the clinicians during their treatment and the results may guide clinical decisions.

Sponsors & Collaborators

Principal Investigators

  • Molly B Kraus · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2022-03-01
Completion
2022-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03579121 on ClinicalTrials.gov